Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Timothy Edward Kubal"'
Autor:
Rami S. Komrokji, Kevin Shahbazian, Wonhee So, Ana Paula Velez, Gisela Caceres, Timothy Edward Kubal, Yasmina S. Salchert, Rod Quilitz, Farnoosh Abbas-Aghababazadeh, John N. Greene, Dahui Qin, Brooke L. Fridley, Kerry Kelly, Jeffrey E. Lancet, Yanina Pasikhova, J. Kevin Hicks, Howard L. McLeod
Publikováno v:
Clin Pharmacol Ther
A risk mitigation strategy was implemented to determine if a higher prophylactic voriconazole dosage in patients with CYP2C19 rapid metabolizer neutropenic acute myeloid leukemia (AML) reduces the incidence of subtherapeutic trough concentrations. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05893cc86237f50d33bc516cb4122d8
https://doi.org/10.1002/cpt.1641
https://doi.org/10.1002/cpt.1641
Autor:
David W. Johnson, Enrico de Belen, Brent Box, Timothy Edward Kubal, Larry Weems, Douglas D. Letson, Catherine Czarnecki, John W. Peabody, Othman Ouenes, David Paculdo
Publikováno v:
The American Journal of Medicine. 132:e778-e785
Rising health care costs, physician shortages, and an aging patient population have increased the demand and utilization of advanced practice providers (APPs). Despite their expanding role in care delivery, little research has evaluated the care deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3695d50dad090d9deda5783950fad9f4
https://doi.org/10.1016/j.amjmed.2019.05.004
https://doi.org/10.1016/j.amjmed.2019.05.004
Autor:
Katherine A. Richter, Seongseok Yun, Sarah J. Rockwell, Amanda Al-Bahou, Timothy Edward Kubal, Matthew Snyder
Publikováno v:
Blood. 138:4043-4043
Background: Acute myeloid leukemia (AML) patients who require intensive induction chemotherapy are traditionally hospitalized for the duration of neutropenia to monitor for treatment-related toxicities. On average, AML patients are hospitalized for 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8adacfd92e109092ad77849aadc5ee
https://doi.org/10.1182/blood-2021-151749
https://doi.org/10.1182/blood-2021-151749
Autor:
Katherine Tobon, Karen Wartenberg, Jeffrey E. Lancet, Amber Lubas, Timothy Edward Kubal, Diedra K. Frantz, Christopher Salamanca, Melissa Smith, Rebecca Nelson
Publikováno v:
Journal of Clinical Oncology. 37:86-86
86 Background: In 2014, due to increased demand for inpatient hospital beds and subsequent patient dissatisfaction due to delays for patients receiving scheduled chemotherapy, Moffitt Cancer Center created a multi-disciplinary team to transition trad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9883458ebfa05ef416944c0c43dd6d6
https://doi.org/10.1200/jco.2019.37.27_suppl.86
https://doi.org/10.1200/jco.2019.37.27_suppl.86
Autor:
Jason M Burkett, Howard L. McLeod, Douglas D. Letson, Neil Thomas Mason, Julio M. Pow-Sang, John W. Peabody, Robert A. Gatenby, Jingsong Zhang, Timothy Edward Kubal, Ryan Nelson
Publikováno v:
Journal of Clinical Oncology. 37:e18343-e18343
e18343 Background: We recently completed a study showing that adaptive abiraterone therapy (AT) led to more than a doubling of the time to radiographic progression (TTP) compared to continuous therapy (CT) in patients with metastatic castration resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55f0bf349df25dece688a0431ec0778a
https://doi.org/10.1200/jco.2019.37.15_suppl.e18343
https://doi.org/10.1200/jco.2019.37.15_suppl.e18343
Publikováno v:
Journal of Clinical Oncology. 37:e18509-e18509
e18509 Background: Patients with acute myeloid leukemia (AML) who achieve complete remission with induction therapy require consolidation therapy. The standard of care consolidation is HIDAC or IDAC depending on age and risk stratification. Consolida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beca974c662a77a6a6b5a3aaa8737ebe
https://doi.org/10.1200/jco.2019.37.15_suppl.e18509
https://doi.org/10.1200/jco.2019.37.15_suppl.e18509
Autor:
John W. Peabody, Gregory M. Springett, Alberto Chiappori, Diana Tamondong Lachica, Riti Shimkhada, Doug G Letson, Timothy Edward Kubal
Publikováno v:
BMJ Open
Objectives This study examined whether a measurement and feedback system led to improvements in adherence to clinical pathways. Design The M-QURE (Moffitt—Quality, Understanding, Research and Evidence) Initiative was introduced in 2012 to enhance a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b0ff81d1e5b6a9d15e2d5515eb104b4
https://pubmed.ncbi.nlm.nih.gov/27625063
https://pubmed.ncbi.nlm.nih.gov/27625063
Autor:
Rami S. Komrokji, Timothy Edward Kubal, David A. Sallman, Christopher Salamanca, Alan F. List, Jeffrey E. Lancet, Kendra Sweet, Eric Padron
Publikováno v:
Journal of Clinical Oncology. 36:e19013-e19013
e19013Background: Liposomal Daunorubicin and Cytarabine (Vxyeos) was recently approved for the treatment of Therapy Related Acute Myeloid Leukemia and AML with Myelodysplastic Related Changes havin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b628a611bd936aff181545dace586daa
https://doi.org/10.1200/jco.2018.36.15_suppl.e19013
https://doi.org/10.1200/jco.2018.36.15_suppl.e19013
Autor:
Dahul Qin, Timothy Edward Kubal, Ana Paula Velez, Kevin Shahbazian, Yanina Pasikhova, Rami S. Komrokji, Rod Quilitz, Howard L. McLeod, J.E. Lancet, James Kevin Hicks, John N. Greene, Wonhee So
Publikováno v:
Journal of Clinical Oncology. 36:6594-6594
6594Background: Acute myeloid leukemia (AML) patients who have prolonged neutropenia are at increased risk of morbidity and mortality due to invasive fungal infections. Voriconazole (VCZ), an effec...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a0b3a3054ffe40775562668ef204415
https://doi.org/10.1200/jco.2018.36.15_suppl.6594
https://doi.org/10.1200/jco.2018.36.15_suppl.6594
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center. 21(4)
Rosai-Dorfman disease (RDD) is a rare, nonmalignant clinical entity characterized by a group of clinical symptoms and characteristic pathological features.Articles that reviewed tumor biology, clinical features, pathology, and treatment for RDD were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58da6e2bb002393f3d268761d6d88cd5
https://pubmed.ncbi.nlm.nih.gov/25310213
https://pubmed.ncbi.nlm.nih.gov/25310213